EIF2A and early-onset autosomal dominant Alzheimer disease: The activated eIF2α induces translational activation of a subset of mRNAs such as BACE1 and ATF4 that are involved in the onset of Alzheimer’s disease and the inhibition of eIF2α activity reduced accumulation of misfolded proteins, ameliorating neurodegeneration in Parkinson’s disease.